The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Search for "Pneumococcal Vaccine"

Search results for: Pneumococcal Vaccine

Synthetic DMARDs May Blunt Pneumococcal Vaccine Response in Systemic Sclerosis

January 24, 2018 • By Scott Baltic

NEW YORK (Reuters Health)—Pneumococcal vaccination yields a satisfactory antibody response in patients with systemic sclerosis (SSc), but synthetic disease-modifying antirheumatic drugs (DMARDs) might reduce the vaccine response in these individuals, according to a report from Sweden. The prospective study, published online Jan. 8 in Rheumatology, evaluated the response to either pneumococcal conjugate vaccine (PCV13) or… [Read More]

Filed Under: Conditions Tagged With: disease-modifying antirheumatic drugs, DMARDs, pneumococcal vaccine, sclerosis, Systemic sclerosis

How Immunosuppression May Affect COVID-19 Vaccine Response

June 13, 2021 • By Ruth Jessen Hickman, MD

Anze Furlan / SHUTTERSTOCK.COM

Although we can expect to learn much more, preliminary data are now available on the potential safety and effectiveness of COVID-19 vaccines in rheumatology patients. The picture is likely to be nuanced, with not all types of immuno­suppressive treatments having identical impacts on vaccine response. Rheumatologists should use caution in interpreting early reports, while continuing… [Read More]

Filed Under: Conditions, Safety Tagged With: COVID-19, immunosuppression, vaccination

The ACR Addresses Vaccine Challenges

February 18, 2021 • By David R. Karp, MD, PhD

An ACR COVID-19 Vaccine task force examined vaccine data and literature to evaluate COVID-19 vaccine safety, efficacy and interaction with medications for patients with rheumatic and musculoskeletal diseases, and to craft a living guidance document for members.... [Read More]

Filed Under: American College of Rheumatology, President's Perspective Tagged With: COVID-19, Dr. David Karp, vaccine

IBD Tied to Higher Risk of Invasive Pneumococcal Disease

September 24, 2015 • By David Douglas

NEW YORK (Reuters Health)—Patients with inflammatory bowel disease (IBD) are at slightly increased risk of invasive pneumococcal disease (IPD), according to Danish researchers. In a paper online Sept. 8 in The American Journal of Gastroenterology, Bjørn Kantsø of Statens Serum Institut in Copenhagen and colleagues note that the inappropriate immune response against infective agents seen in… [Read More]

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: Crohn's disease, inflammatory bowel disease, lung, pneumococcal vaccine

Project Increases Pneumococcal Vaccination Rates in Rheumatology Patients

August 26, 2015 • By Will Boggs, MD

NEW YORK (Reuters Health)—A multicomponent intervention can significantly increase pneumococcal vaccination rates in pediatric rheumatology patients, researchers report. “The interventions outlined in our article can easily be implemented in pediatric rheumatology practices or other subspecialty clinics,” Dr. Julia G. Harris from Children’s Mercy Hospital, Kansas City, Mo., told Reuters Health by email. “It takes additional… [Read More]

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: Pediatric Rheumatology, pneumococcal vaccine, vaccination

Vaccines and Biologics: What Rheumatologists Need to Know

December 1, 2014 • By Kurt Ullman

How vaccines, medications and rheumatic disease-related effects on immune system interact... [Read More]

Filed Under: Biologics & Biosimilars, Drug Updates Tagged With: Biologics, Immune System, interaction, Research, Rheumatic Disease, rheumatologist, rheumatology, rituximab, Ullman, vaccines

ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines

February 1, 2013 • By Thomas R. Collins

People with rheumatic diseases can be considered to receive flu and pneumococcal vaccines even if they’re on immunosuppressive drugs... [Read More]

Filed Under: Conditions, Meeting Reports Tagged With: Drugs, Immune System, patient care, vaccine

A Shot of Wisdom: Vaccinations in Patients with Rheumatic Disease

December 2, 2022 • By Jason Liebowitz, MD

PHILADELPHIA—The treatment of rheumatic diseases is often a double-edged sword: immunosuppressive regimens can be very effective in reducing disease activity, but the cost of such treatments may be seen in the form of increased risk of infection. At ACR Convergence 2022, the session titled ACR Guidelines for Vaccination in Patients with Rheumatic and Musculoskeletal Diseases… [Read More]

Filed Under: ACR Convergence, Conditions, Guidelines, Meeting Reports Tagged With: ACR Convergence 2022, COVID-19, vaccination

The State of Clinical Research in Vasculitis: 2021

January 19, 2021 • By Shubhasree Banerjee, MD, & Peter A. Merkel, MD, MPH

ilusmedical / shutterstock.com

It is an exciting time in the world of vasculitis research. More clinical studies and trials are being conducted now than at any time in history. In the past ten years, four drugs have been approved by the U.S. Food & Drug Administration (FDA) and other regulatory agencies specifically for the treatment of vasculitis: Rituximab… [Read More]

Filed Under: Conditions, Research Reviews, Vasculitis Tagged With: registry

How to Watch for Immune Deficiencies & Manage Risk

July 19, 2018 • By Thomas R. Collins

CHICAGO—When a patient with rheumatic disease suffers recurrent infections, has a history of multiple autoimmune diseases or presents with atypical autoimmune syndromes, clinicians should consider the possibility of an immune deficiency, an expert said at the ACR State-of-the-Art Clinical Symposium in April. W. Winn Chatham, MD, professor of medicine at the University of Alabama at… [Read More]

Filed Under: Conditions Tagged With: 2018 State of the Art Clinical Symposium, CVID, Immune System, lympopenia, neutropenia

  • 1
  • 2
  • 3
  • Next Page »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)